Bibliography

Export 44 results:

Filters: Keyword is Research Support, U.S. Gov't, P.H.S. [Clear All Filters]

2005

Rogers CC, Alloway RR, Buell JF, Boardman R, Alexander JW, Cardi M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation. 2005;80(1):26-33.

Rogers CC, Hanaway M, Alloway RR, Alexander JW, Boardman RE, Trofe J, et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc. 2005;37(2):795-7.

Otley CC, Cherikh WS, Salasche SJ, McBride MA, Christenson LJ, Kauffman HM. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol. 2005;53(5):783-90.

2003

Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation. 2003;75(4):482-7.

Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation. 2003;75(8):1336-41.

Chen GG, Merchant JL, Lai PB, Ho RL, Hu X, Okada M, et al. Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89. Am J Pathol. 2003;162(6):1823-9.

Loren AW, Desai S, Gorman RC, Schuchter LM. Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma. Transplantation. 2003;76(4):741-3.

2002

Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors1. Transplantation. 2002;73(4):579-82.

Alexander JW, Stanley LL, Ofstedal TL, First MR, Cardi MA, Safdar S, et al. Transplantation without steroids. Transplant Proc. 2002;34(6):2076-8.

2000

Baehner R, Magrane G, Balassanian R, Chang C, Millward C, Wakil AE, et al. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Hum Pathol. 2000;31(11):1425-9.

Stephens JK, Everson GT, Elliott CL, Kam I, Wachs M, Haney J, et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation. 2000;70(1):232-6.

Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation. 2000;70(12):1747-51.

1999

Mielcarek M, Bryant E, Loken M, Torok-Storb B, Storb R. Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation. Br J Haematol. 1999;105(2):361-5.

Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94(7):2208-16.

1998

Lin HM, Kauffman HM, McBride MA, Davies DB, Rosendale JD, Smith CM, et al. Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. Jama. 1998;280(13):1153-60.

Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood. 1998;91(6):1833-44.

1997

Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336(13):897-904.

1992

Alexander JW, Babcock GF, First MR, Davies CB, Madden RL, Munda R, et al. The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial. Transplantation. 1992;53(2):423-7.

1991

Fisher RA, Tchervenkov JI, Schroeder TJ, Alexander JW, Munda R, Penn I, et al. Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin. Transplant Proc. 1991;23(1 Pt 2):1253-5.

1988

Feig SA, Dreazen O, Simon M, Wiley F, Schreck R, Gale RP. B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL. Bone Marrow Transplant. 1988;3(4):331-7.

1985

Witherspoon RP, Schubach W, Neiman P, Martin P, Thomas ED. Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood. 1985;65(5):1172-4.

Smith JL, Heerema NA, Provisor AJ. Leukaemic transformation of engrafted bone marrow cells. Br J Haematol. 1985;60(3):415-22.

Blazar BR, Orr HT, Arthur DC, Kersey JH, Filipovich AH. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood. 1985;66(6):1436-44.

1984

Deeg HJ, Sanders J, Martin P, Fefer A, Neiman P, Singer J, et al. Secondary malignancies after marrow transplantation. Exp Hematol. 1984;12(8):660-6.

1982

Boyd CN, Ramberg RC, Thomas ED. The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res. 1982;6(6):833-7.

Pages